WHO and ILO put tuberculosis social protection on a measurable footing
The World Health Organization and the International Labour Organization have released a new monitoring and evaluation framework designed to help countries track progress toward universal social protection for people with tuberculosis. The document arrives at a practical moment: governments have already committed to covering every person with TB with a health and social benefits package by 2027, yet commitment alone does not reveal whether support is reaching patients, whether it arrives early enough, or whether it is broad enough to prevent financial collapse at home.
TB is still treated as an infection, but the damage often extends far beyond the lungs. People affected by TB and their households may face transport costs, diagnostic expenses, repeated clinic visits, time away from work, and lost income while treatment continues. Across countries that have conducted national TB household cost surveys, nearly half of people treated for TB and their households experience catastrophic costs. That figure is not just an economic statistic; it reflects treatment interruptions, delayed care-seeking, and the kind of household strain that can undermine recovery even when the antimycobacterial regimen is available.
The new framework is built to make those consequences visible to health systems and social protection agencies at the same time.
A phased monitoring model for countries with uneven data capacity
The framework uses a phased approach that can be adapted to countries with different social protection systems, different levels of data availability, and different monitoring capacity. In practice, that matters because countries do not begin from the same baseline. Some already have mature administrative systems and linked databases; others rely on fragmented records or periodic surveys. A single rigid metric would miss large parts of that reality, while a phased design gives countries a way to start with what they have and strengthen measurement over time.
This approach is meant to build on existing health and social protection monitoring systems rather than replace them. The emphasis is on progressively improving measurement of whether people with TB are actually reached, protected, and supported in a timely and adequate way. A benefits package can exist on paper and still fail in clinical life if patients cannot access it when they need it, if eligibility rules are opaque, or if support does not cover the real costs of treatment completion.
One sentence captures the entire policy problem: coverage without effective access is not protection.
Financial hardship remains a clinical barrier, not a side issue
TB care is long enough to expose household fragility. Patients may spend weeks or months moving between diagnosis, treatment initiation, follow-up visits, and symptom monitoring. During that time, income loss can be as disruptive as drug toxicity or coexisting illness. The framework treats these pressures as part of the disease burden rather than as background social context, which is clinically appropriate because financial strain can shape adherence, retention in care, and completion of therapy.
The WHO and ILO describe social protection as a way to reduce financial hardship and improve health and social outcomes. In TB, that logic is straightforward. When transport, income loss, and nonmedical costs are not absorbed by social support systems, the patient absorbs them personally, often at the precise moment when uninterrupted treatment matters most. Households that fall into catastrophic costs may defer food, borrow money, or cut back on essential spending, all of which can compound vulnerability during an already prolonged illness.
The framework therefore focuses on whether support is timely, adequate, and comprehensive. Those three measures are central. A delayed benefit can still leave a patient unable to attend appointments. An inadequate benefit may reduce but not remove financial toxicity. A narrow benefit may ignore the indirect costs that most often drive hardship.
Linking TB control with labor and social policy
The document also reflects a broader structural point: TB control does not sit entirely inside ministries of health. Shahra Razavi of the ILO framed universal social protection as essential to ensuring that people with TB and their families are protected from the social and economic consequences of illness. That is not simply a policy statement. It describes a disease whose burden is distributed across health services, workplaces, households, and public benefit systems.
The framework is intended to strengthen collaboration across sectors so that countries can identify gaps, improve programmes, and accelerate progress toward universal social protection inclusive of people with TB. This is where public health measurement becomes operational. If health authorities can see whether diagnosed patients are linked to benefits, and social protection systems can see whether their coverage is reaching the people most exposed to treatment-related hardship, then gaps become easier to name and harder to ignore.
The release also connects the framework to WHO’s Multisectoral Accountability Framework to end TB, or MAF-TB. That linkage matters because TB elimination efforts have repeatedly shown that medical treatment alone is not enough to achieve durable progress. Accountability across sectors gives countries a way to track whether social protection commitments are being converted into real-world coverage rather than remaining policy statements.
From commitment to verification by 2027
At the 2023 United Nations General Assembly High-Level Meeting on TB, Member States committed to ensuring that 100% of people with TB have access to a health and social benefits package by 2027. The new framework gives countries a practical way to assess whether that target is moving from declaration to delivery. It also creates a method for identifying where coverage fails: in enrolment, in timeliness, in benefit adequacy, or in the range of services included.
Dr Tereza Kasaeva of WHO described the framework as a step toward translating the global commitment into measurable action. The clinical significance of that statement is hard to overstate. TB outcomes depend not only on microbiology and regimen choice but also on whether patients can stay engaged with care long enough to complete treatment. Social protection is part of that continuity, especially when the illness threatens employment or household stability.
The most immediate challenge is not defining the goal. It is measuring whether patients truly receive the support promised to them.
A related WHO-ILO publication, the 2024 guidance on social protection for people affected by tuberculosis, provides the policy foundation. This new framework extends that work into the monitoring phase, where countries must prove whether systems are functioning as intended. For TB programmes, that shift from guidance to measurement is likely to determine whether social protection remains an aspirational add-on or becomes a routine part of disease control.